Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
FREMONT, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (NASDAQ: CSLR), a leading solar technology, services, and installation company, today...
-
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...
-
Promising results support the potential of epidural glucose monitoring for simplified disease management for patients with painful diabetic neuropathy Rutherford, NJ, May 16, 2024 (GLOBE NEWSWIRE)...
-
LOS ANGELES, May 16, 2024 (GLOBE NEWSWIRE) -- PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), announced today its newest podcast, We (Almost) Made...
-
Quarter Driven by Capital Restructuring to Prioritize Financial Stability for Long-Term Revenue Growth. First quarter 2024 net income of $4.9mn versus net loss of $49.9mn for the prior year...
-
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 16, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors,...
-
ATLANTA, May 16, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
-
Successfully Acquires Ten Brokerages Since Company’s IPO in October 2023 Residential Real Estate Services Revenue Increased 211% to $10.2 Million in Q1 2024 vs Q1 2023 CELEBRATION, Fla., May 16,...
-
53.66% and 141.14% Increase in Gross Profit and Net Income from Continuing Operations for Full Year 2023 Compared to Full Year 2022, RespectivelyRimawari-kun Members Reached 279,029 as of December 31,...
-
Fort Lee, NJ, May 16, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative...